Comparison of Syphilis Treatment Drug Effects by VDRL Titer Monitoring
- Author:
Jeong soo LEE
1
;
Nuri NA
;
Joon soo PARK
Author Information
1. Department of Dermatology, School of Medicine, Catholic University of Daegu, Daegu, Korea
- Publication Type:Original Article
- From:Korean Journal of Dermatology
2020;58(9):590-595
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Despite the increasing number of syphilis cases, there has been a considerable lack of recent data comparing the efficacy and duration of benzathine penicillin G, ceftriaxone, and tetracycline in Korean patients.
Objective:To compare the efficacy and duration of benzathine penicillin, ceftriaxone, and tetracycline in Korean patients with syphilis.
Methods:We retrospectively reviewed 145 cases of syphilis from 2004 to 2019 and statistically analyzed the treatment efficacy and duration.
Results:Patients in the benzathine penicillin, ceftriaxone, and tetracycline treatment groups showed no significant statistical difference in terms of treatment rate (chi-square test, p=0.962). Similarly, treatment duration among groups was not statistically significant (one-way analysis of variance, p=0.792). Co-infection with human immunodeficiency virus resulted in reduced treatment rate (p=0.016) and increased treatment duration (p=0.007).
Conclusion:This retrospective study showed no significant difference between penicillin, ceftriaxone, and tetracycline in terms of treatment rate and duration. However, a difference in treatment rate and duration was evident between the non-infection and HIV co-infection groups.ng
